Grifols reported EUR411.56M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Alaunos Therapeutics USD -1.19M 148K Sep/2025
aTyr Pharma USD -226.49K 140.85K Sep/2025
GlaxoSmithKline GBP 2.79B 716M Sep/2025
Grifols EUR 411.56M 15.51M Sep/2025